Caplacizumab: frequent local skin reactions

Ann Hematol. 2021 Dec;100(12):3051-3052. doi: 10.1007/s00277-020-04260-7. Epub 2020 Sep 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Erythema / chemically induced*
  • Erythema / pathology
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects*
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Injections
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Single-Domain Antibodies / administration & dosage
  • Single-Domain Antibodies / adverse effects*
  • Single-Domain Antibodies / therapeutic use
  • Skin / drug effects*
  • Skin / pathology

Substances

  • Fibrinolytic Agents
  • Single-Domain Antibodies
  • caplacizumab